11.07.2015 Views

Novel genetic and epigenetic alterations in ... - Ous-research.no

Novel genetic and epigenetic alterations in ... - Ous-research.no

Novel genetic and epigenetic alterations in ... - Ous-research.no

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

DiscussionIt may seem like unnecessary work to perform a scann<strong>in</strong>g method s<strong>in</strong>ce it must becomplemented with a diag<strong>no</strong>stic method anyway. Why <strong>no</strong>t just go for the diag<strong>no</strong>stic method<strong>and</strong> get all results <strong>in</strong> one analysis? The answer is that different problems require differentsolutions. If the mutation is already described <strong>and</strong> we k<strong>no</strong>w what we are look<strong>in</strong>g for, thediag<strong>no</strong>stic approach may be used. The BRAF, KRAS <strong>and</strong> PIK3CA genes have k<strong>no</strong>wnmutation hotspots, <strong>in</strong> which a diag<strong>no</strong>stic method like direct sequenc<strong>in</strong>g is highly suitable. Forgenes with large cod<strong>in</strong>g regions <strong>and</strong> <strong>no</strong> k<strong>no</strong>wn hotspots (exemplified by NF1) a scann<strong>in</strong>gmethod is quite useful. Direct sequenc<strong>in</strong>g of the 61 NF1 exons <strong>in</strong> 24 carc<strong>in</strong>omas wouldrequire a m<strong>in</strong>imum of ~1500 sequences with a 100% success rate, mean<strong>in</strong>g the f<strong>in</strong>al numberwould be higher. In paper III we pre-screened all 61 exons <strong>in</strong> 24 samples for NF1 mutationsus<strong>in</strong>g denatur<strong>in</strong>g high performance liquid chromatography (DHPLC) <strong>and</strong> only those with anab<strong>no</strong>rmal elution profile were subjected to direct sequenc<strong>in</strong>g. The employment of a scann<strong>in</strong>gapproach saved us from perform<strong>in</strong>g a large amount of unnecessary sequenc<strong>in</strong>g, result<strong>in</strong>g <strong>in</strong> amore time <strong>and</strong> cost effective approach.Denatur<strong>in</strong>g high performance liquid chromatographyDHPLC was first described <strong>in</strong> 1995[145] <strong>and</strong> today several DHPLC-systems arecommercially available, such as the MultiMax LH 750 (Ra<strong>in</strong><strong>in</strong> Instrument, Woborn, MA,USA) <strong>and</strong> the WAVE systems (Transge<strong>no</strong>mic, Crewe, UK). The pr<strong>in</strong>ciple for detection ofmutations is temperature-based separation of homoduplex <strong>and</strong> heteroduplex moleculesunder partial denatur<strong>in</strong>g conditions[146]. DHPLC detects both s<strong>in</strong>gle base-pair mismatches<strong>and</strong> <strong>in</strong>dels of s<strong>in</strong>gle <strong>and</strong> multiple bases with success, but are unsuccessful at detect<strong>in</strong>g largege<strong>no</strong>mic rearrangements.In paper III the WAVE system was used for the DHPLC analysis. Separation of DNAmolecules is achieved by means of a mobile phase of hydro-organic eluent conta<strong>in</strong><strong>in</strong>gtriethylammonium acetate (TEAA) <strong>and</strong> acetonitrile, <strong>and</strong> a solid phase consist<strong>in</strong>g of a columnwith hydrophobic beads. Dur<strong>in</strong>g the mobile phase the system is first flushed with TEAA,caus<strong>in</strong>g the beads to be “coated” with positively charged triethylammonium ion (TEA). TEAis an amphiphilic ion, mean<strong>in</strong>g it has both hydrophobic <strong>and</strong> hydrophilic ends. This makesthe negatively charged DNA molecule able to b<strong>in</strong>d to the positive end of TEA, l<strong>in</strong>k<strong>in</strong>g the48

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!